Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial

Por Raghu, Ganesh, van den Blink, Bernt, Hamblin, Mark J., Brown, A. Whitney, Golden, Jeffrey A., Ho, Lawrence A., Wijsenbeek, Marlies S., Vasakova, Martina, Pesci, Alberto, Antin-Ozerkis, Danielle E., Meyer, Keith C., Kreuter, Michael, Santin-Janin, Hugues, Mulder, Geert-Jan, Bartholmai, Brian, Gupta, Renu, Richeldi, Luca
Publicado no JAMA (2018)

Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary Fibrosis

Por Ryu, Changwan, Sun, Huanxing, Gulati, Mridu, Herazo-Maya, Jose D., Chen, Yonglin, Osafo-Addo, Awo, Brandsdorfer, Caitlin, Winkler, Julia, Blaul, Christina, Faunce, Jaden, Pan, Hongyi, Woolard, Tony, Tzouvelekis, Argyrios, Antin-Ozerkis, Danielle E., Puchalski, Jonathan T., Slade, Martin, Gonzalez, Anjelica L., Bogenhagen, Daniel F., Kirillov, Varvara, Feghali-Bostwick, Carol, Gibson, Kevin, Lindell, Kathleen, Herzog, Raimund I., Dela Cruz, Charles S., Mehal, Wajahat, Kaminski, Naftali, Herzog, Erica L., Trujillo, Glenda
Publicado no Am J Respir Crit Care Med (2017)